References
- Wise RA.. The role of reward pathways in the development of drug dependence. Pharmacol Ther. 1987; 35: 227–263. [PUBMED], [INFOTRIEVE]
- Richardson NR, Roberts DC.. Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci. 1991; 49: 833–840. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Essman WD, Singh A, Lucki I.. Serotonergic properties of cocaine: effects on a 5-HT2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine. Pharmacol Biochem Behav. 1994; 49: 107–113. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pradhan SN, Battacharyya AK, Pradhan S.. Serotoninergic manipulation of the behavioral effects of cocaine in rats. Communications in Psychopharmacology. 1978; 2: 481–486. [PUBMED], [INFOTRIEVE]
- Galloway MP.. Regulation of dopamine and serotonin synthesis by acute administration of cocaine. Synapse. 1990; 6: 63–72. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Leshner AI, Koob GF.. Drugs of abuse and the brain. Proceeding of the Association of American Physicians. 1999; 111: 99–108. [CSA], [CROSSREF]
- Broderick PA.. In vivo electrochemical studies of gradient effects of (SC) cocaine on dopamine and serotonin release in dorsal striatum of conscious rats. Pharmacol Biochem Behav. 1993; 46: 973–984. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Broderick PA, Kornak EP, Jr, Eng F, Wechsler R.. Real time detection of acute (IP) cocaine-enhanced dopamine and serotonin release in ventrolateral nucleus accumbens of the behaving Norway rat. Pharmacol Biochem Behav.. 1993; 46: 715–722. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Herges S, Taylor DA.. Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat. Pharmacol Biochem Behav.. 1998; 59: 595–611. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- de Lima MS, de Oliveira Soares BG, Reisser AA, Farrell M.. Pharmacological treatment of cocaine dependence: a systematic review. Addiction. 2002; 97: 931–949. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Walsh SL, Preston KL, Sullivan JT, Fromme R, Bigelow GE.. Fluoxetine alters the effects of intravenous cocaine in humans. J Clin Psychopharmacol. 1994; 14: 396–407. [PUBMED], [INFOTRIEVE], [CSA]
- Batki SL, Manfredi LB, Jacob P, 3rd, Jones RT.. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Psychopharmacol. 1993; 13: 243–250. [PUBMED], [INFOTRIEVE]
- Batki SL, Washburn AM, Delucchi K, Jones RT.. A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend. 1996; 41: 137–142. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schmitz JM, Rhoades HM, Elk R, Creson D, Hussein I, Grabowski J.. Medication take-home doses and contingency management. Exp Clin Psychopharmacol. 1998; 6: 162–168. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schmitz JM, Averill P, Stotts AL, Moeller FG, Rhoades HM, Grabowski J.. Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug Alcohol Depend. 2001; 63: 207–214. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cornelius JR, Salloum IM, Thase ME, et al, Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Psychopharmacol Bull. 1998; 34: 117–121. [PUBMED], [INFOTRIEVE], [CSA]
- Grabowski J, Rhoades H, Elk R, et al, Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials. J Clin Psychopharmacol. 1995; 15: 163–174. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Covi L, Hess JM, Kreiter NA, Haertzen CA.. Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse. 1995; 21: 327–344. [PUBMED], [INFOTRIEVE], [CSA]
- Fernstrom JD, Wurtman RJ.. Brain serotonin content: physiological dependence on plasma tryptophan levels. Science. 1971; 173: 149–152. [PUBMED], [INFOTRIEVE]
- Tagliamonte A, Biggio G, Vargiu L, Gessa GL.. Free tryptophan in serum controls brain tryptophan level and serotonin synthesis. Life Sci.. 1973; 12: 277–287. [CROSSREF]
- Carroll ME, Lac ST, Asencio M, Kragh R.. Intravenous cocaine self-administration in rats is reduced by dietary tryptophan. Psychopharmacology (Berl). 1990; 100: 293–300
- McGregor A, Lacosta S, Roberts DC.. L-tryptophan decreases the breaking point under a progressive ratio schedule of intravenous cocaine reinforcement in the rat. Pharmacol Biochem Behav. 1993; 44: 651–655. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Satel SL, Krystal JH, Delgado PL, Kosten TR, Charney DS.. Tryptophan depletion and attenuation of cue-induced craving for cocaine. Am J Psychiatry. 1995; 152: 778–783. [PUBMED], [INFOTRIEVE]
- Aronson SC, Black JE, McDougle CJ, et al, Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology (Berl). 1995; 119: 179–185
- Higgins ST, Delaney DD, Budney AJ, et al, A behavioral approach to achieving initial cocaine abstinence. Am J Psychiatry. 1991; 148: 1218–1224. [PUBMED], [INFOTRIEVE]
- Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg F, Badger G.. Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry. 1993; 150: 763–769. [PUBMED], [INFOTRIEVE]
- Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ.. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry. 1994; 51: 568–576. [PUBMED], [INFOTRIEVE]
- Silverman K, Higgins ST, Brooner RK, et al, Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry. 1996; 53: 409–415. [PUBMED], [INFOTRIEVE], [CSA]
- Signorini DF, Leung O, Simes RJ, Beller E, Gebski VJ, Callaghan T.. Dynamic balanced randomization for clinical trials. Stat Med. 1993; 12: 2343–2350. [PUBMED], [INFOTRIEVE]
- Ashcroft GW, Crawford TBB, Cundall RL, et al, 5-hydroxytryptamine metabolism in affective illness: the effect of tryptophan administration. Psychol Med.. 1973; 3: 326–332. [PUBMED], [INFOTRIEVE]
- Coppen A, Shaw DM, Herzberg B, Maggs R.. Tryptophan in the treatment of depression. Lancet. 1967; 2: 1178–1180. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Babiker IE, Cooke PR, Gillett MG.. How useful is riboflavin as a tracer of medication compliance?. J Behav Med.. 1989; 12: 25–38. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fuller RK, Branchey L, Brightwell DR, et al, Disulfiram treatment of alcoholism: a veterans administration cooperative study. JAMA. 1986; 256: 1449–1455. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Preston KL, Silverman K, Schuster CR, Cone EJ.. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction. 1997; 92: 717–727. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Follmann D, Wu M.. An approximate generalized linear model with random effects for informative missing data. Biometrics. 1995; 51: 151–168. [PUBMED], [INFOTRIEVE]
- Cunningham KA, Paris JM, Goeders NE.. Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding. Synapse. 1992; 11: 112–123. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Buydens-Branchey L, Branchey M, Hudson J, Rothman M, Fergeson P, McKernin C.. Serotonergic function in cocaine addicts: prolactin responses to sequential D,L-fenfluramine challenges. Biol Psychiatry. 1999; 45: 1300–1306. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McGregor A, Lacosta S, Roberts DC.. L-tryptophan decreases the breaking point under a progressive ratio schedule of intravenous cocaine reinforcement in the rat. Pharmacol Biochem Behav. 1993; 44: 651–655. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Young SN.. The effect on aggression and mood of altering tryptophan levels. Nutr Rev.. 1986; 44, (Suppl). 112–122. [PUBMED], [INFOTRIEVE]
- Kapur S, Ganguli R, Ulrich R, Raghu U.. Use of random-sequence riboflavin as a marker of medication compliance in chronic schizophrenics. Schizophr Res. 1991; 6: 49–53. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jacobsen LK, Staley JK, Malison RT, et al, Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. Am J Psychiatry. 2000; 157: 1134–1140. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chutuape MA, Silverman K, Stitzer M.. Contingent reinforcement sustains post-detoxification abstinence from multiple drugs: a preliminary study with methadone patients. Drug Alcohol Depend. 1999; 54: 69–81. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Katz EC, Chutuape MA, Jones HE, Stitzer ML.. Voucher reinforcement for heroin and cocaine abstinence in an outpatient drug-free program. Exp Clin Psychopharmacol. 2002; 10: 136–143. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Higgins ST, Badger GJ, Budney AJ.. Initial abstinence and success in achieving longer term cocaine abstinence. Exp Clin Psychopharmacol. 2000; 8: 377–386. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Higgins ST, Alessi SM, Dantona RL.. Voucher-based incentives. a substance abuse treatment innovation. Addict Behav. 2002; 27: 887–910. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]